Interferon receptors

Biotherapy

Volumn 8, Issue 3-4, 1996, Pages 163-174

  Langer, Jerome ^a,b   Garotta, Gianni ^a   Pestka, Sidney ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Interferon; Receptors; Signal transduction

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON ANTAGONIST; HYBRID PROTEIN; INTERFERON; INTERFERON RECEPTOR; SOLUBLE RECEPTOR; UNCLASSIFIED DRUG;

GENE EXPRESSION; HUMAN; IMMUNOGENICITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECOMBINANT DNA TECHNOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INTERFERON TYPE I; INTERFERON TYPE II; RECEPTORS, INTERFERON;

EID: 0030004343     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01877201     Document Type: Review

References (112)

1. Abramovich C, Shulman LM, Ratovitski E, Harroch S, Tovey M, Eid P, Revel M. Differential tyrosine phosphorylation of the IFNAR chain of the Type I Interferon receptor and of an associated surface protein in response to IFN-α and IFN-β. EMBOJ 1994; 13: 5871-7.
2. AbramovichC, Gottlieb H.Chebath J, Revel M. Human Type I interfere (IFN) receptor protein: Differential response to various human IFN species in mouse and hamster cells. J Interferon Res 1991; 11, Suppl 1: S201.
3. 125I-labeled mouse Interferon to a specific cell surface receptor. Nature (London) 1980; 284: 768-70.
4. Aguet M, Dembic Z, Merlin G. Molecular cloning and expression of the human interferon-γ receptor. Cell 1988; 55: 273-80.
5. Barbieri G, Velazquez L, Schrobogna M, Fellous M, Pellegrini S. Activation of the protein kinase Tyk2 by interferon α/β. Eur J Biochem 1994; 223: 427-35.
6. Barbieri G, Velazquez L, Cheung K, Ling L, Gauzzi C, Fellous M, Pellegrini M. Structure-function analysis of the protein tyrosine kinase Tyk2. J Interferon Res 1994; 14: S49.
7. Benoit P, Maguire D, Plavec I, Kocher H, Tovey M, Meyer F. A monoclonal antibody to recombinant human IFN-α receptor inhibits biologic activity of several species of human IFN-α, IFN-β and IFN-ω. J Immunol 1993; 150 707-16.
8. Branca AA, Baglioni C. Evidence that Type I and U interferons have different receptors. Nature (London) 1981; 294: 768-70.
9. Cleary CM, Donnelly RJ, Soh J, Mariano TM, Lim J-K, Langer JA, Pestka S. Knockout and reconstitution of a functional human type I interferon receptor YAC expressed in hamster cells. J Interferon Res 1994; 14: S89.
10. Cleary CM, Donnelly RJ, Soh J, Mariano TM, Pestka S. Knockout and reconstitution of a functional human Type I receptor complex. J Biol Chem 1994; 269: 18747-9.
11. CofanoF, Moore SK.TanakaS.YuhkiN.LandolfoS.Appella E. Affinity purification, peptide analysis and cDNA sequence of the mouse interferon-γ receptor. J Biol Chem 1990; 265: 4064-71.
12. Cohen A, HanniganGE, Williams BRG, Ling wood C A. Roles for globosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem 1987; 262: 17088-91.
13. Cohen B, Novick D, Rubinstein M. Identification of amino acids of the IFN-α/β receptor that interact with Jakl and its potential substrates. J Interferon Res 1994; 14: S49.
14. Colamonici OR. Structure and functional characterization of the Type I IFN receptor. J Interferon Res 1994; 14: S92. Authors, please see remark on p. 22 of manuscript
15. Colamonici OR, D'Alessandro F, Diaz MO, Gregory SA, Neckers LM, Nordan R. Characterization of three monoclonal antibodies that recognize the interferon α2 receptor. Proc N all Acad Sei USA 1990; 87: 7230-4.
16. Colamonici OR, Domanski P. Identification of a novel subunit of the Type I interferon receptor localized to human chromosome 21. J Biol Chem 1993; 268: 10895-9.
17. Colamonici OR, Pfeffer LM. Structure of the human interferon alpha receptor. Pharmacol Therapeut 1991; 52: 227-33. Authors, please see remark on p. 22 of manuscript
18. Colamonici OR, Pfeffer LM, D'Alessandro F, Platanias LC, Gregory SA, Rosolen A, Nordan R, Cruciani RA, Diaz MO. Multichain structure of the interferon α receptor on hematopoietic cells. J Immunol 1992; 148: 2126-32.
19. Colamonici OR, Porterneid B, Domanski P, Constantinescu S, Pfeffer LM. Complementation of the interferon α response in resistant cells by expression of the cloned subunit of the interferon α receptor. J Biol Chem 1994; 269: 9598-602.
20. tyk2, an interferon-α-activated tyrosine kinase, is physically associated with an interferon-α receptor. J Biol Chem 1994; 269: 3518-22.
21. tyk2 tyrosine kinase. Molec Cell Biol 1994; 14: 8133-42.
22. Constantinescu SN, Croze E, Wang C, Murti A, Basu L, Mullersman JE, Pfeffer LM. Role of interferon α/β receptor Chainl in the structure and transmembrane signaling of the interferon α/β receptor complex. Proc Natl Acad Sei USA 1994; 91: 9602-6.
23. Constantinescu SN, Croze E, Wang C, Pfeffer LM. The IFNaRl chain of the IFN α/β receptor complex acts as a species-specific signal transducer. J Interferon Res 1994; 14: S85.
24. Cook JR, Emanuel SL, Donnelly RJ, Soh J, Mariano TM, Schwanz B, Rhee S, Pestka S. Sublocalization of the human interferon-gamma receptor accessory factor gene and characterization of accessory factor activity by yeast artificial chromosomal fragmentation. J Biol Chem 1994; 269: 7013-8.
25. Cook JR, Jung V, Schwanz B, Wang P, Pestka S. Structural analysis of the human interferon-gamma receptor. Specific requirement of a small segment of the intraceular domain for Class IMHC antigen induction and antiviral activity. Proc Nati Acad Sei USA 1992; 89: 11317-21.
26. Danilkovich A, Romashkova J, Freze K. Cell sensitivity to growth inhibition by synthetic peptide fragment of interferon alpha depends on the presence of human chromosome 21. J Interferon Res 1994; 14: S100.
27. Debets R, Savelkoul HFJ. Cytokine antagonists and their potential therapeutic use. Immunol Today 1994; 15: 455-7.
28. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-52.
29. Farrar MA, Campbell JD, Schreiber RD. Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor, Proc Natl Acad Sei USA 1992, 89: 11706-10.
30. Femandez-Botran R. Soluble cytokine receptors; Their role in immunoregulation. FASEB J 1991; 5: 2567-74.
31. Flores I, Mariano TM, Pestka S. Human interferon omega (ω) Binds to the α/β receptor. J Biol Chem 1991; 266: 19875-7.
32. Fountoulakis M, Juranville JF, Staber D, Weibel EK, Garotta G. Purification and biochemical characterization of a soluble human interferon-γ receptor expressed in E. coli. J Biol Chem 1990; 265:13268-75.
33. Fountoulakis M,KaniaM,OzmenL, Lötscher HR, Garotta G, Van Loon A. Structure and membrane topology of the high-affinity receptor for human IFN-γ: Requirement for binding IFN-γ. J Immunol 1989; 143: 3266-76.
34. Fridman WH, Teillaud JL, Bouchard C, et al. Soluble Fcγ receptors. J Leukoc Biol 1993; 54: 504-12.
35. Friedman RM. Interferon binding: The first step in establishment of antiviral activity. Science 1967; 156: 1760-1.
36. Garotta G, Ozmen L, Fountoulakis M. Development of IFN-γ antagonists as an example of biotechnology application to approach new immunomodulators. Pharmacol Res 1989; 21, Suppl 2: 5-17.
37. Garotta G, Ozmen L, Fountoulakis M, Dembic Z, Van Loon A, Stuber D. Human IFN-γ Receptor Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor protein. J Biol Chem 1990; 265: 6908-15.
38. Gentz R, Hayes A, Grau N, Fountoulakis M, Lahm H-W, Ozmen L, Garotta G. Analysis of soluble human and mouse interferon-γ receptors expressed in eukaryotic cells. Eur J Biochem 1990; 210: 545-54.
39. Ghislain J, Lingwood CA, Fish EN. Evidence for glycosphingolipid modification of the Type I Interferon receptor. J Immunol 1994; 153: 3655-63.
40. Gibbs VC, Williams SR, Gray PW, Schreiber RD, Pennica D, Rice G, Goeddel DV. The extracellular domain of the human interferon gamma receptor interacts with a species-specific signal transducer. Mol Cell Biol 1991; 11: 5860-6.
41. Gray PW, Leong S, Fennie EH, Farrar MA, Pingel JT, Fernandez-Luna J, Schreiber RD. Cloning and expression of the cDNA for the murine interferon-γ receptor. Proc Natl Acad Sei USA 1989; 86: 8497-501.
42. Hemmi S, Böhni R, Aguet M. Functional characterization of the cytoplasmic domain of the IFN-γ receptor. J Interferon Res 1994; 14: S94.
43. Hemmi S, Böhni R, Stark G, Di Marco F, Aguet M. A novel member of the interferon receptor family complements functionality of the murine interferon-gamma receptor in human cells. Cell 1994; 76: 803-10.
44. Hemmi S, Merlin G, Aguet M. Functional characterization of a hybrid human-mouse interferon-γ receptor: Evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer. Proc Natl Acad Sei USA 1992; 89: 2737-41.
45. Hemmi S, Peghini P, Metzler M, Merlin G, Dembic Z, Aguet M. Cloning of murine interferon-γ receptor cDNA: Expression in human cells mediates high affinity binding but is not sufficient to confer sensitivity to murine interferon-γ. Proc Natl Acad Sei USA 1989; 86: 9901-5.
46. Hertzog PJ, Hwang SY, Holland KA, Tymms MJ, lannello R, Kola I. A gene on human chromosome 21 located in the region 21q22.2 to 21q22.3 encodes a factor necessary for signal transduction and antiviral response to Type I interferons. J Biol Chem 1994; 269: 14088-93.
47. Hibino Y, KumarCS, Mariano TM, Lai D, Pestka S. Chimeric interferon gamma receptors demonstrate an accessory factor required for activity interacts with the extracellular domain. J Biol Chem 1992; 267: 3741-9.
48. Hibino Y, Mariano TM, Kumar CS, Kozak CA, Pestka S. Expression and reconstitution of a biologically active mouse interferon gamma receptor in hamster cells: Chromosome location of an accessory factor. J Biol Chem 1991; 266:6948-51.
49. Hu RQ, Gan Y, Liu J, Miller D, Zoon KC. Evidence for multiple binding sites for several components of human lymphoblastoid interferon-α. J Biol Chem 1993; 268:12591-5.
50. Hu RQ, Zoon KC. Hu-IFNA21 gene expression and properties of recombinant IFNA21. J Interferon Res 1994; 14: S98.
51. Jung V, Jones C, Kumar CS, Stefanos S, O'Connell S, Pestka S. Expression and reconstitution of a biologically active human interferon gamma receptor in hamster cells. J Biol Chem 1990; 265: 1827-30.
52. Jung V, Jones C, Rashidbaigi A, Geyer DD, Morse HG, Wright RB, Pestka S. Chromosome mapping of biological pathways by fluorescence-activated cell sorting and cell fusion: The human interferon gamma receptor as a model system. Somatic Cell Molec Genet 1988; 14: 583-92.
53. Jung V, Pestka S. Selection and screening of transformed NIH3T3 cells for enhanced sensitivity to human interferons α and β. Methods Enzymol 1986; 119: 597-611.
54. Jung V, Rashidbaigi A, Jones C, Tischfield JA, Shows TB, Pestka S. Human chromosomes 6 and 21 ate required for sensitivity to human interferon gamma. Proc Natl Acad Sei USA 1987; 84:4151-5.
55. Kaiina U, Ozman L, Dadova KD, Gentz R, Garotta G. The human gamma interferon receptor accessory factor encoded by chromosome 21 transduces the signal for the induction of 2′,5′-oligoadenylate-synthetase, resistance to virus cytopathic effect, and major histocompatibility complex Class I antigens. J Virology 1993; 67: 1702-6.
56. Korn AP, Rose DR, Fish EN. Three-dimensional model of a human interferon-α consensus sequence. J Interferon Res 1994; 14: 1-9.
57. Kotenko SV, Izotova LS, Pollack BP, Mariano TM, Garotta G, Pestka S. Interaction between the component chains of the interferon gamma receptor. J Interferon Res 1994; 14: S93.
58. Kurnar CS, Muthukumaran G, Frost LJ, Noe M, Ahn Y-H, Mariano TM, Pestka S. Molecular characterization of the murine interferon gamma receptor cDNA. J Biol Chem 1989; 264: 17939-46.
59. Kürschner C, Garotta G, Dembic Z. Construction, Purification and characterization of new interferon gamma (IFN-γ) inhibitor proteins: Three IFN-γ receptor-immunoglobulin hybrid molecules. J Biol Chem 1992; 267: 9354-60.
60. Kürschner C, Ozmen L, Garotta G, Dembic Z. Half-life, Immunogenicity and in vivo activity of gamma interferon receptor-immunoglobulin hybrid molecules. J Immunol 1992; 149:4096-100.
61. Lai D, Donnelly R, Zhu X, Garotta G, Pestka S. A specific aroino acid of the extracellular domain is required for signal transduction. J Interferon Res 1994; 14: S96.
62. Landolfo S, Garotta G. Interferon-γ a lymphokine that modulates immunological and inflammatory responses. J Immunol Res 1991; 3: 81-94.
63. Langer JA, Pestka S. Interferon receptors. Immunol Today 1988; 9: 393-9. Authors, please see remark on p. 22 of manuscript
64. Langer JA, Rashidbaigi A, Lai L-W, Patterson D, Jones C. Sublocalization on chromosome 21 of human interferon-alpha receptor and the gene for an interferon-gamma response protein. Somat Cell Mol Genet 1990; 16: 231-40.
65. Lembo D, Ricciardi P, Alber G, Ozman L, Landolfo S, Bllithmann H, Dembic Z, Kotenko S, Donnelly R, Pestka S, Garotta G. Mouse cells with both subunits of the human IFNγ receptor respond to human IFNγ but are not efficiently protected from viral cytopathic effect. J Interferon Res 1994; 14: S94.
66. Lengyel P. Biochemistry of interferons and their actions. Ann Rev Biochem 1982; 51:251-82.
67. Lim J-K, Langer JA. Cloning and characterization of a bovine alpha interferon receptor. Biochim Biophys Acta 1993; 1173: 314-9.
68. Lim J-K, Xiong J, Carrasco N, Langer JA. Intrinsic ligand binding properties of the human and bovine α-interferon receptors. FEBS Lett 1994; 350: 281-6.
69. Lutfalla G, Gardiner K, Proudhon D, Vielh E, Uzé G. The structure of the human interferon α/β receptor gene. J Biol Chem 1992; 267: 2802-9.
70. Lutfalla G, Roeckel N, Mogensen KE, Mattel M-G, Uzé G. Assignment of the human interferon-α receptor gene to chromosome 21q22.2 by in situ hybridization. J Interferon Res 1990; 10: 515-7.
71. Mariano TM, Soh J, Lim J-K, Izotova L, Mirochnitchenko O, Schwanz B, Langer JA, Pestka S. Expression of a functional human Type I Interferon receptor in hamster cells: Application of functional YAC screening. J Interferon Res 1994; 14: S92.
72. Mitsui Y, Senda T, Shimazu T, Matsuda S, Utsumi J. Structure, Functional and evolutionary implications of the three-dimensional crystal structure of murine Interferon-β. Pharmacol Ther 1993; 58: 93-132.
73. Mouchel-Vielh E, Lutfalla G, Mogensen KE, Uzé G. Specific antiviral activities of the human α interferons are determined at the level of receptor (IFNAR) structure. FEBS Lett 1992; 313: 255-9.
74. Müller U, Steinhoff U, Reis LFL, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of Type I and Type II interferons in antiviral defense. Science 1994; 264: 1918-21.
75. Munro S, Maniatis T. Expression cloning of the murine interferon-γ receptor cDNA. Proc Natl Acad Sei USA 1989; 86: 9248-52.
76. Muthukumaran G, Donnelly RJ, Mariano TM, Wang N, Adamson C, Pestka S, Kozak CA. Mapping of the mouse Interferon γ receptor accessory factor (AF-1) gene to the distal end of chromosome sixteen. J Interferon Res 1994; 14: S93.
77. Novick D, Cohen B, Rubinstein M. The human interferon α/β receptor: Characterization and molecular cloning. Cell 1994; 77: 391-400.
78. Novick D, Cohen B, Rubinstein M. The human interferon-α/β receptor: Characterization and molecular cloning. J Interferon Res 1994; 14: S88.
79. Novick D, Cohen B, Rubinstein M. Soluble interferon-α receptor molecules are present in body fluids. FEBS Lett 1992; 314: 445-8.
80. Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med 1989; 170: 1409-14.
81. Ozmen L, Fountoulakis M, Gentz R, Garotta G. Immunomodulation with soluble IFN-γ receptor: Preliminary studies. Int Rev Exp Pathol 1993; 34B: 137-47.
82. Ozmen L, Fountoulakis M, Stüber D, Garotta G. The human IFN-γ receptor as tool for the discovery of new immunomodulatory drugs. In: Crommelin DJA, Schellekens H, eds. From clone to clinic. Dordrecht: Kluwer Academic Publishers, 1990: 283-9.
83. Ozmen L, Gentz R, Fountoulakis M, Blutmann H, Stüber D, Garotta G. Preliminary characterization of soluble IFN-γ receptor as an immunomodulatory agent. J Chemotherapy 1991 ;3:99-102.
84. Ozmen L, Gribaudo G, Fountoulakis M, Gentz R, Landolfo S, Garotta G. Mouse Soluble IFN-γ Receptor as IFN-γ Inhibitor: Distribution, antigenicity and activity after injection in mice. J Immunol 1993; 150: 2698-705.
85. Ozmen L, Roman D, Fountoulakis M, et al. Soluble IFN-γ receptor: A therapeutically useful drug for systemic lupus erythematosus. J Interferon Res 1994; 14: 283-4.
86. Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G. The treatment with mouse soluble IFN-γR inhibits lupus-like glomerulonephritis in [NZB/W]F1 mice. Eur J Immunol (in press).
87. Pellegrini S, John J, Shearer M, Kerr IM, Stark GR. Use of a selectable marker regulated by alpha interferon to obtain invitations in the signaling pathway. Mol Cell Biol 1989; 9: 4605-12.
88. Pestka S. Functional Type I and Type II interferon receptors: The Odyssey. J Interferon Res 1994; 14: S87.
89. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Ann Rev Biochem 1987; 56:727-77.
90. Platanias LC, Colamonici OR. Interferon α induces rapid tyrosine phosphorylation of the α subunit of its receptor. J Biol Chem 1992; 267: 24053-7.
91. Platanias LC, Pfeffer LM, Cruciani R, Colamonici OR. Characterization of the a subunit of the IFN-α receptor. Evidence of N- and O-linked glycosylation and association with other surface proteins. J Immunol 1993; 150: 3382-8.
92. Platanias LC, Uddin S, Colamonici OR. Tyrosine phosphorylation of the α and β subunits of the Type I interferon receptor: Interferon-β selectively induces tyrosine phosphorylation of an α subunit-associated protein. J Biol Chem 1994; 269: 17761-4.
93. Rashidbaigi A, Langer JA, Jung V, Jones C, Morse HG, Tischfield J, Trill JJ, Kung H-F, Pestka S. The gene for the human immune interferon receptor is located on chromosome 6. Proc Natl Acad Sei USA 1986; 83: 384-8.
94. Raz R, Durbin JE, Levy DE. Cloning of the acute phase response factor, an ISGF3 homologue that integrates the diverse signals from interferons. J Interferon Res 1994; 14: S50.
95. Revel M, Cohen B, Abramovich C, Novick D, Rubinstein M, Shulman L. Components of the human Type I IFN receptor system. J Interferon Res 1991; 11: S61.
96. Rhee S, Donnelly RJ, Pestka S. Structure of the gene for the human IFN-gamma receptor accessory factor-1. J Interferon Res 1994; 14: S96.
97. Rousseau V, Cremer I, Lauret E, Muller U, Riviere I, Vieillard V, Aguet M, De Maeyer E. The antiviral activity of autocrine IFN-β requires the presence of the IFN-α/β receptor. J Interferon Res 1994; 14: S100.
98. Senda T, Shimazu T, Matsuda S, Kawano G, Shimizu H, Nakamura KT, Mitsui Y. Three-dimensional crystal structure of recombinant marine interferon-β. EMBO J 1992; 11: 3193-201.
99. Soh J, Donnelly RJ, Kotenko S, Mariano TM, Cook JR, Wang N, Emanuel SL, Schwartz B, Miki T, Pestka S. Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell 1994; 76: 793-802.
100. Soh J, Donnelly RJ, Mariano TM, Cook JR, Schwartz B, Pestka S. Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon gamma receptor: Evidence for multiple accessory factors. Proc Natl Acad Sei USA 1993; 90: 8737-41.
101. Soh J, Mariano TM, Lim J-K, Izotova L, Mirochnitchenko O, Schwartz B, Langer JA, Pestka S. Expression of a functional human Type I interferon receptor in hamster cells: Application of functional YAC screening. J Biol Chem 1994; 269: 18102-10.
102. Stüber D, Friedlein A, Fountoulakis M, Lahm H-W, Garotta G. Alignment of disulfide bonds of the extracellular domain of the interferon γ receptor and investigation of their role in biological activity. Biochemistry 1993; 32:2423-30.
103. Upton C, Mossman KK, McFadden G. Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 1992; 258: 1369-72.
104. Uzé G, Lutfalla G, Bandu M-T, Proudhon D, Mogensen KE. Behavior of a cloned murine interferon α/β receptor expressed in homospecific or heterospecific background. Proc Natl Acad Sei USA 1992; 89:4774-8.
105. Uzé G, Lutfalla G, Eid P, Maury C, Bandu MT, Grosser I, Mogensen K. Murine tumor cells expressing the gene for the human Interferon alpha beta receptor elicit antibodies in syngeneic mice to the active form of the receptor. Eur J Immunol 1991; 21: 447-51.
106. Uzé G, Lutfalla G, Grosser I. Genetic transfer of a functional human Interferon α receptor into mouse cells: Cloning and expression of its cDNA. Cell 1990; 60: 225-34.
107. Uzé G, Lutfalla G, Mogenson KB. α and β Interferons and their receptor and their friends and relatives. J Interferon Cytokine Res 1995; 15: 3-26.
108. Valente G, Ozmen L, Novelli F, Geuna M, Palestra G, Forni G, Garotta G. Distribution of interferon-γ receptor in human tissues. Eur J Immunol 1992; 22:2403-12.
109. Van Loon A, Ozmen L, Fountoulakis M, Kania M, Haiker M, Garotta G. High affinity receptor for IFN-γ, a ubiquitous protein occurring in different molecular forms on human cells. J Leukoc Biol 1991; 49: 462-73.
110. Vasilenko AV, Navolotskaya EV, Roslovtseva OA, Zav'yalov VP. Localization of the site on Hu-IFN-α2 responsible for the competition of IFN, prothymosin-α and cholera toxin β-subunits for common receptors on human fibroblasts. J Interferon Res 1994; 14: S97.
111. Velazquez L, Fellous M, Stark GR, PeUegrini S. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 1992; 70: 313-22.
112. Woith W, Nüsslein I, Antoni C, et al. A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro. Clin Exp Immunol 1993; 92: 537-42.